Serious renal damage is a possible consequence of long-term abuse of anabolic steroids, data show .
SAN DIEGO—Pre-dialysis transplant recipients with a high level of kidney function do not appear to benefit from their transplant more than pre-dialysis recipients with a low level of kidney function, data show.
Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN’s Renal Week 2009.
Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN’s Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.
Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN’s Renal Week 2009.
It may be possible to detect acute allograft rejection in kidney transplant patients by urinary proteome analysis, according to a new German study that was presented at ASN’s Renal Week 2009.
Among pediatric renal transplant recipients, increased age and having a very high or very low BMI, steroid use at the time of hospital discharge are three independent factors associated with an increased risk of new onset diabetes, according to new data presented at ASN’s Renal Week 2009.
An intensified-dosing regimen of enteric-coated mycophenolate sodium in combination with basiliximab and standard doses of cyclosporine may result in a lower rate of rejection without compromising safety and tolerability, according to new data presented at ASN’s Renal Week 2009.
Please login or register first to view this content.